Akebia Therapeutics, Inc. (AKBA): Depreciation & Amortization
Older than the company's other figures. The latest Depreciation & Amortization is for the year ended 2022-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.
$1.65M
Year ended 2022-12-31
-9.7%
3-year compound annual growth
+21.8%
5-year compound annual growth
| Period ended | Depreciation & Amortization | Change YoY | Source filing |
|---|---|---|---|
| 2022-12-31 | $1.65M | -14.2% | 2023-08-28, From 2022-01-01 |
| 2021-12-31 | $1.93M | -7.1% | 2023-08-28, From 2021-01-01 |
| 2020-12-31 | $2.08M | -7.6% | 2023-08-28, From 2020-01-01 |
| 2019-12-31 | $2.25M | +149.7% | 2022-03-01, From 2019-01-01 |
| 2018-12-31 | $899.0K | +45.7% | 2021-02-25, From 2018-01-01 |
| 2017-12-31 | $617.0K | +108.4% | 2020-03-12, From 2017-01-01 |
| 2016-12-31 | $296.0K | +208.3% | 2019-03-26, From 2016-01-01 |
| 2015-12-31 | $96.0K | +95.9% | 2018-03-12, From 2015-01-01 |
| 2014-12-31 | $49.0K | n/a | 2017-03-06, From 2014-01-01 |